International Consortium of Investigative Journalists, November 14, 2019. The FDA needs to require better research before implants are approved and put in patients’ bodies, instead of just counting problems after the implants are used by thousands of patients.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
FDA Advisers Hear About Problems, Research Needs With Metal Implants
MedPage Today, November 14, 2019. Comparing different implants could prevent many women and men from harm resulting from metals and other substances that set off negative reactions in patients.
Read More »FDA’s Special Treatment Of Big Tech Faces Mounting Scrutiny
Kevin Stawicki, Law360, November 12, 2019. The U.S. Food and Drug Administration is taking heat from prominent lawmakers over a special approval pathway for health software products sold by Apple, Samsung and other major tech companies, opening the door to a congressional showdown over whether the agency has the right to start such a program. The […]
Read More »How the FDA and EPA’s Failure to Communicate Could Put Patients in Danger
Politico, November 7, 2019. While EPA wants to shut down facilities that sterilize medical devices using a carcinogenic chemical, the EPA and FDA should have harmonized their standards years ago to protect patients and consumers.
Read More »As Essure Implant Return Deadline Nears, FDA Study Enrollment Inches Up
MedTech Dive, November 5, 2019. The original clinical data supporting FDA’s approval of Essure was insufficient, as seen in Bayer’s small sample size in the Essure postmarket study.
Read More »